Health and Healthcare
FDA: Thin Blood, Sour Stomach (AZN)(BMY)(SNY)
Published:
Last Updated:
The FDA is routinely criticized for being a poor steward of drug research and pharmaceutical side effects. The agency proved once again why much of the criticism is justified.
The FDA today said that two drugs, each of which has been on the market for many years, react badly when taken together. It is a wonder it took so long to figure this out since each of the drugs is very widely used.
Prilosec, an antacid marketed by AstraZeneca (NYSE:AZN), hurts the effectiveness of Plavix which is the world’s most prescribed blood thinner, Plavix is marketed by Sanofi-Aventis (NYSE:SNY) and Bristol-Myers (NYSE:BMY).
Plavix is essential to the treat heart attack victims, patients with vascular stents, and also helps prevent blood clots in the brain. Any drop in its effectiveness is likely to cause real danger to many patients using Plavix.
The FDA is slow to market with news, once again.
Douglas A. McIntyre
Want to Retire Early? Start Here (Sponsor)
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
